Retatrutide appears to be a new medication in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating https://safiyazpbi562621.wssblogs.com/36101105/tirzepatide-a-promising-new-treatment-for-obesity